Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Content:; Colorectal Cancer Diagnosis -- Screening for Colorectal Carcinoma -- Histopathology -- Chemotherapy and Colorectal Cancer -- Robotics for Rectal Cancer -- lncRNA NLIPMT Inhibitors in Colorectal Cancer Management -- Pathways in Colorectal Cancer -- Radiotherapy in Colorectal Cancer -- Surv…
Full conference information obtained from the Annual cancer conference program and abstracts. See ID# 15548. (QZ200 B366 2006); Colorectal screening by Dr. Barbara Melosky (25 minutes); Treating advanced colorectal cancer : new challenges by Dr. Hagen Kennecke (25 minutes)
c.1 BC Cancer Agency VAN Library AV Room | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
Epidemiology and risk factors of colorectal cancer by Kathryn M. Chu; Presentation and initial evaluation of colorectal cancer by Susan Tsai and Susan L. Gearhart; Hereditary colorectal cancer and polyp syndromes by Francis M. Giardiello; Genetic screening by Cheryl J. Pendergrass; Behavior and die…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VIC Library | Available |
Table of Contents:; 1. Immunotherapy administration; 2. Immunotherapy; 3. Cancer immunotherapy; 4. CAR T-cell therapy; 5. Cytokine release syndrome; 6. Developming infrastructure; 7. Immunotherapy toxicities; 8. Checkpoint inhibitors; 9. Toxicity managment; 10.Oncolytic viruses
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available |